US FDA Authorizes Covid-19 Booster Shots of Pfizer for 12 to 15 Years Teens


On Monday, 3rd January 2021, the Food and Drug Administration (FDA) of the United States has given the clearance to the corona virus booster dose developed by Pfizer and BioNTech for the children between the ages of 12 and 15 years.

The Omicron covid-19 variant has been spreading rapidly among the young people in the United States, and the country has asset a record for the total patients hospitalized in the country with the suspected and confirmed corona virus, which has been pointing to the need for the young teenagers for getting the vaccine in the United States.

The US FDA has also shortened the timing for the booster shots of the company Pfizer from the time period of six months to five months after the primary series of the shots for everyone that are over the age of 12 years, and this change in the corona virus booster recommendation to five months after the primary series means that, million more people of the United States is now going to be eligible for an extra dose of the corona virus vaccine booster shots.

READ  Novavax Covid-19 Vaccine is 90% Effective in US Trials

Currently, only around 33 percent of the eligible people in the United States have now received a booster corona virus vaccine shots as per the US CDC although the two doses of the Pfizer corona virus vaccine has been decreasing the effective against the Omicron corona virus variant, and the reduced time period of waiting for the booster vaccine only applies to the people, who had received the Pfizer corona virus vaccine shots.